SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-224194
Filing Date
2022-08-18
Accepted
2022-08-18 17:10:50
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d301543ds3.htm S-3 343551
2 EX-1.2 d301543dex12.htm EX-1.2 192528
3 EX-5.1 d301543dex51.htm EX-5.1 28411
4 EX-23.2 d301543dex232.htm EX-23.2 1887
5 EX-FILING FEES d301543dexfilingfees.htm EX-FILING FEES 48239
6 GRAPHIC g301543g05p36.jpg GRAPHIC 49303
7 GRAPHIC g301543g0818090010310.jpg GRAPHIC 1769
8 GRAPHIC g301543g63y94.jpg GRAPHIC 4180
  Complete submission text file 0001193125-22-224194.txt   688758
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 (415) 529-5055
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266963 | Film No.: 221178117
SIC: 2834 Pharmaceutical Preparations